310
Participants
Start Date
September 30, 2015
Primary Completion Date
June 30, 2020
Study Completion Date
June 30, 2020
Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013
Prophylaxis for prevention of bleeding, various regimens.
Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013
Prophylaxis for prevention of bleeding, various regimens.
Weill Cornell Medicine, New York
Mary M. Gooley Hemophilia Center, Rochester
The Hemophilia Center of Western Pennsylvania, Pittsburgh
Children's Hospital of Philadelphia (CHOP), Philadelphia
Pennsylvania Comprehensive Hemophilia and Thrombophilia Program / Hospital of the University of Pennsylvania, Philadelphia
Children's National Medical Center, Washington D.C.
Johns Hopkins University Medical Center, Baltimore
Children's Healthcare of Atlanta/Emory, Atlanta
St. Joseph's Children's Hospital, Tampa
Johns Hopkins All Children's Hospital, St. Petersburg
St Jude Children's Research Hospital, Memphis
Indiana Hemophilia and Thrombosis Center (IHTC), Indianapolis
University of Michigan Hemophilia and Coagulation Disorders Program, Ann Arbor
Michigan State University Center for Bleeding and Clotting Disorders, East Lansing
Blood Center of Wisconsin, Milwaukee
Bleeding and Clotting Disorders Institute, Peoria
Children's Mercy Hospital, Kansas City
Louisiana Center for Bleeding and Clotting Disorders, New Orleans
UTSW Medical Center at Dallas/Children's Medical Center, Dallas
University of Colorado Denver Hemophilia and Thrombosis Center, Aurora
University of California San Diego (UCSD), San Diego
Oregon Health and Science University, Portland
Washington Center for Bleeding Disorders Bloodworks Northwest d/b/a Puget Sound Blood Center, Seattle
Yale Hemophilia Treatment Center, New Haven
Maine Hemophilia and Thrombosis Center, Scarborough
Boston Hemophilia Center at Children's Hospital of Boston, Boston
Dartmouth-Hitchcock Comprehensive Hemophilia and Thrombosis Center, Lebanon
Collaborators (4)
Shire
INDUSTRY
CSL Behring
INDUSTRY
Bioverativ Therapeutics Inc.
INDUSTRY
Bayer
INDUSTRY
American Thrombosis and Hemostasis Network
NETWORK